- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.07. | Bullion Gold Discoveries Corp: Bullion Gold private placement | 1 | Stockwatch | ||
| 30.06. | Bullion Gold Discoveries Corp: Bullion Gold samples 5.4 g/t Au at Terragold project | 1 | Stockwatch | ||
| BULLION GOLD DISCOVERIES Aktie jetzt für 0€ handeln | |||||
| 30.06. | Bullion Gold Discoveries Corp.: Bullion Reports 5.4 g/t Au and 5.0 g/t Ag in Surface Grab Sample and Commences Validation Drilling at Terragold | 405 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 30, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to provide an exploration update from Bullion's flagship and... ► Artikel lesen | |
| 23.06. | Bullion Gold Discoveries Corp: Bullion shareholders approve all matters at AGM | 1 | Stockwatch | ||
| 23.06. | Bullion Gold Discoveries Corp.: Bullion Announces Results of Annual General Meeting | 766 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 22, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce the voting results from its Annual General Meeting... ► Artikel lesen | |
| 18.06. | XFRA NEW INSTRUMENTS AVAILABLE ON 18.06.2026 | 446 | Xetra Newsboard | The following instruments on XETRA do have their first trading 18.06.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 18.06.2026
Aktien
1 SE0029278985 Tangen Industrikapital... ► Artikel lesen | |
| 17.06. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 17.06.2026 | 438 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 17.06.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 17.06.2026ISIN NameCA1202272029 BULLION... ► Artikel lesen | |
| 17.06. | Bullion Gold Discoveries Corp: Bullion Gold closes $2-million private placement | 1 | Stockwatch | ||
| 17.06. | XFRA ISIN CHANGE | 296 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA1202272029 Bullion Gold Discoveries Corp. 17.06.2026 CA1199331093 Bullion Gold Discoveries Corp. 18.06.2026 Tausch... ► Artikel lesen | |
| 17.06. | Bullion Gold Discoveries Corp.: Bullion Closes $2M Private Placement | 438 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 17, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce that it has closed its previously announced non-brokered... ► Artikel lesen | |
| 17.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 17.06.2026 | 384 | Xetra Newsboard | Das Instrument EA20 NO0013601245 EAM SOLAR AS NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 17.06.2026 und ex Kapitalmassnahme am 18.06.2026 The instrument EA20 NO0013601245 EAM SOLAR AS NK... ► Artikel lesen | |
| 16.06. | XFRA B4R: AUSSETZUNG/SUSPENSION | 186 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBULLION GOLD RES... ► Artikel lesen | |
| 13.06. | Bullion Gold Resources Corp (2): Bullion Gold name change to Bullion Gold Discoveries | 6 | Stockwatch | ||
| 12.06. | Bullion Gold Resources Corp. kündigt Namensänderung an | 1 | GoldSeiten.de | ||
| 12.06. | Bullion Gold Resources Corp (2): Bullion Gold Resources to change name | 1 | Stockwatch | ||
| 11.06. | Bullion Gold Resources Corp.: Bullion Announces Name Change to Bullion Gold Discoveries Corp | 594 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 11, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce that it will complete a name change from "Bullion... ► Artikel lesen | |
| 09.06. | Bullion Gold Resources Corp (2): Bullion Gold moves field crew to Terragold | 1 | Stockwatch | ||
| 09.06. | Bullion Gold Resources Corp.: Bullion Mobilizes Field Team to Terragold Project and Increases Private Placement to $2 Million | 434 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 9, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce that its field team has been mobilized to Bullion's... ► Artikel lesen | |
| 02.06. | Bullion Gold Resources Corp (2): Bullion arranges $1.5-million private placement | 2 | Stockwatch | ||
| 02.06. | Bullion Gold Resources Corp.: Bullion Announces $1.5 Million Private Placement | 408 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 2, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce a private placement of up to 16,666,667 units of... ► Artikel lesen |
1 2 3 Weiter >>
53 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AMYLYX PHARMACEUTICALS | 39,640 | -0,05 % | Kaum zu fassen: Die unglaubliche Biotech-Story von Amylyx Pharmaceuticals | Der Biotech-Sektor ist immer wieder für faustdicke Überraschungen gut - sowohl negativ als auch positiv. Bei Amylyx Pharmaceuticals gibt es am Dienstag keine zwei Meinungen: Die Aktie des Biotech-Unternehmens... ► Artikel lesen | |
| KINIKSA PHARMACEUTICALS | 78,47 | 0,00 % | Kiniksa Pharmaceuticals International, Plc: Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution | - ARCALYST (rilonacept) Q2 2026 net product revenue of $243.6 million, representing ~55% year-over-year growth -- ARCALYST 2026 expected net product revenue increased to $980 - $995 million -- KPL-387... ► Artikel lesen | |
| QIAGEN | 38,735 | +3,05 % | DAX Gewinner am Mittwoch: Qiagen Aktie | Kursentwicklung und Chartanalyse | ||
| PRAXIS PRECISION MEDICINES | 364,38 | -0,05 % | Raymond James raises Praxis Precision Medicines price target on pipeline outlook | ||
| APOGEE THERAPEUTICS | 134,78 | +0,02 % | AbbVie schließt Anleiheemission über 8,0 Mrd. US-Dollar zur Finanzierung der Übernahme von Apogee Therapeutics ab | ||
| NURIX THERAPEUTICS | 27,050 | 0,00 % | Biotech Stocks At 52-Week Highs - DCTH +22% On Q2 Results, ANRO, COAG, MNPR, NRIX | SOUTH SAN FRANCISCO (dpa-AFX) - The following biotech stocks reached 52-week highs on August 7, 2026, driven by key catalysts such as positive quarterly reports or upcoming conference participation.... ► Artikel lesen | |
| ADMA BIOLOGICS | 9,760 | 0,00 % | Kehoe Law Firm, P.C.: ADMA Biologics (ADMA) Shareholder Alert: Kehoe Law Firm Investigates Potential Fiduciary Duty Breaches | Philadelphia, Pennsylvania--(Newsfile Corp. - August 5, 2026) - Kehoe Law Firm, P.C. is investigating whether certain officers and directors of ADMA Biologics, Inc. ("ADMA," "ADMA Biologics," or... ► Artikel lesen | |
| ARCUTIS BIOTHERAPEUTICS | 25,360 | +0,04 % | Arcutis Biotherapeutics, Inc.: Arcutis Expands Board of Directors with Appointment of Chris Peetz | WESTLAKE VILLAGE, Calif., July 16, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovation in... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 12,430 | 0,00 % | Could Arcus Biosciences (RCUS) and Summit Therapeutics (SMMT)'s Cancer Drug Partnership Create a New Treatment Standard? | ||
| COGENT BIOSCIENCES | 35,310 | 0,00 % | Cogent Biosciences, Inc.: Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM) | Submission based on results of APEX pivotal trial which demonstrated bezuclastinib objective response rate (CR+CRh+PR+CI) of 65% per mIWG criteria and 81% ORR per PPR criteria with a well-tolerated... ► Artikel lesen | |
| ENLIVEN THERAPEUTICS | 59,02 | +0,17 % | Barclays startet Coverage für Enliven Therapeutics mit "Overweight" und Kursziel von 78 Dollar | ||
| RECURSION PHARMACEUTICALS | 3,335 | -0,15 % | Recursion, Novavax and Crispr Stocks Trending in Pre-Market-Here's Why | ||
| STRUCTURE THERAPEUTICS | 50,52 | 0,00 % | Structure Therapeutics Inc.: Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel | SAN FRANCISCO, April 14, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for... ► Artikel lesen | |
| JADE BIOSCIENCES | 21,230 | 0,00 % | Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors | SAN FRANCISCO and VANCOUVER, British Columbia, June 26, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (the "Company" or "Jade") (Nasdaq: JBIO), a clinical-stage biotechnology company focused on... ► Artikel lesen | |
| TANGO THERAPEUTICS | 23,520 | 0,00 % | H.C. Wainwright hebt Kursziel für Tango Therapeutics auf 68 US-Dollar an |
Das Unternehmen BULLION GOLD DISCOVERIES CORPORATION kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,040 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLION GOLD DISCOVERIES CORPORATION finden Sie auf Wallstreet Online.